Выбор редакции

More on Momenta Q2 results

  • Momenta Pharmaceuticals (MNTA -3.5%) Q2 results: Collaboration revenue: $11.0M (+151.1%); Operating Expenses: $37.3M (+11.3%); Operating Loss: ($26.4M) (+9.3%); Net Loss: ($26.2M) (+9.0%); Loss Per Share: ($0.51) (+5.3%); Quick Assets: $202.3M (-17.7%).
  • 2014 Guidance: Operating expenses: $28M - 30M per quarter; cash burn: ~$26M per quarter.
Post your comment!
НОВОСТИ ПО ТЕМЕ